These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28855409)

  • 21. Cognitive impairment in adult myotonic dystrophies: a longitudinal study.
    Sansone V; Gandossini S; Cotelli M; Calabria M; Zanetti O; Meola G
    Neurol Sci; 2007 Mar; 28(1):9-15. PubMed ID: 17385090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
    Voermans NC; van der Bilt RC; IJspeert J; Hogrel JY; Jeanpierre M; Behin A; Laforet P; Stojkovic T; van Engelen BG; Padberg GW; Sacconi S; Lemmers RJLF; van der Maarel SM; Eymard B; Bassez G
    J Neurol; 2019 Dec; 266(12):2987-2996. PubMed ID: 31471688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysphagia is present but mild in myotonic dystrophy type 2.
    Tieleman AA; Knuijt S; van Vliet J; de Swart BJ; Ensink R; van Engelen BG
    Neuromuscul Disord; 2009 Mar; 19(3):196-8. PubMed ID: 19167224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study.
    D'Ambrosio ES; Chuang K; David WS; Amato AA; Gonzalez-Perez P
    Muscle Nerve; 2023 Aug; 68(2):142-148. PubMed ID: 36790141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.
    Gliem C; Minnerop M; Roeske S; Gärtner H; Schoene-Bake JC; Adler S; Witt JA; Hoffstaedter F; Schneider-Gold C; Betz RC; Helmstaedter C; Tittgemeyer M; Amunts K; Klockgether T; Weber B; Kornblum C
    PLoS One; 2019; 14(3):e0213381. PubMed ID: 30845252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in diffusion tensor imaging parameters of brain white matter tracts between patients with myotonic dystrophy type 1 and type 2 - a retrospective single-centre study.
    Maj E; Wolak T; de Meulder J; Janiszewska K; Wojtaszek M; Kostera-Pruszczyk A; Gołębiowski M; Łusakowska A
    Neurol Neurochir Pol; 2023; 57(5):430-437. PubMed ID: 37706668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of tumor development in patients with myotonic dystrophy.
    Das M; Moxley RT; Hilbert JE; Martens WB; Letren L; Greene MH; Gadalla SM
    J Neurol; 2012 Oct; 259(10):2161-6. PubMed ID: 22619053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.
    Romeo V; Pegoraro E; Ferrati C; Squarzanti F; Sorarù G; Palmieri A; Zucchetta P; Antunovic L; Bonifazi E; Novelli G; Trevisan CP; Ermani M; Manara R; Angelini C
    J Neurol; 2010 Aug; 257(8):1246-55. PubMed ID: 20221771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.
    Romigi A; Franco V; Placidi F; Liguori C; Rastelli E; Vitrani G; Centonze D; Massa R
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):102. PubMed ID: 30382420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic odyssey of patients with myotonic dystrophy.
    Hilbert JE; Ashizawa T; Day JW; Luebbe EA; Martens WB; McDermott MP; Tawil R; Thornton CA; Moxley RT
    J Neurol; 2013 Oct; 260(10):2497-504. PubMed ID: 23807151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to capture activities of daily living in myotonic dystrophy type 2?
    Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
    Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Greek National Cross-Sectional Study on Myotonic Dystrophies.
    Papadimas GK; Papadopoulos C; Kekou K; Kartanou C; Kladi A; Nitsa E; Sofocleous C; Tsanou E; Sarmas I; Kaninia S; Chroni E; Tsivgoulis G; Kimiskidis V; Arnaoutoglou M; Stefanis L; Panas M; Koutsis G; Karadima G; Traeger-Synodinos J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability of multisystemic features in myotonic dystrophy type 1--lessons from Serbian registry.
    Rakocevic-Stojanovic V; Peric S; Basta I; Dobricic V; Ralic V; Kacar A; Peric M; Novakovic I
    Neurol Res; 2015 Nov; 37(11):939-44. PubMed ID: 26184384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in myotonic dystrophies from a multisystemic perspective.
    Montagnese F; Schoser B
    Curr Opin Neurol; 2021 Oct; 34(5):738-747. PubMed ID: 33990102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High disease impact of myotonic dystrophy type 2 on physical and mental functioning.
    Tieleman AA; Jenks KM; Kalkman JS; Borm G; van Engelen BG
    J Neurol; 2011 Oct; 258(10):1820-6. PubMed ID: 21461958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong association between myotonic dystrophy type 2 and autoimmune diseases.
    Tieleman AA; den Broeder AA; van de Logt AE; van Engelen BG
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1293-5. PubMed ID: 19864666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.